Pactiv Evergreen Inc. Common stock
PTVE
PTVE was delisted on the 31st of March, 2025.
142 hedge funds and large institutions have $448M invested in Pactiv Evergreen Inc. Common stock in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 53 reducing their positions, and 22 closing their positions.
262% more call options, than puts
Call options by funds: $442K | Put options by funds: $122K
6% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 53
4% less funds holding
Funds holding: 148 → 142 (-6)
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
20% less capital invested
Capital invested by funds: $559M → $448M (-$111M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$21.3M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.23M |
| 3 |
EP
Edgestream Partners
Princeton,
New Jersey
|
+$2.77M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$2.46M |
| 5 |
Goldman Sachs
New York
|
+$2.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$4.17M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$3.31M |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$2.82M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.23M |
| 5 |
Millennium Management
New York
|
-$1.99M |
PTVE Hedge Fund Activity: Q2 2024 in Review
142 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Pactiv Evergreen Inc. Common stock (PTVE) for Q2 2024, worth a combined $448M — down 20% from $559M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of PTVE and 18 opened new positions — a net loss of 4 holders — while 53 trimmed existing stakes and 56 added.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $21.3M. The largest seller was Morgan Stanley, cutting an estimated $4.17M.
- 142 institutional investors held Pactiv Evergreen Inc. Common stock (PTVE) as of Q2 2024, down from 148 in Q1 2024.
- Funds reported $448M of Pactiv Evergreen Inc. Common stock stock for Q2 2024, down 20% quarter-over-quarter.
- 18 funds opened new Pactiv Evergreen Inc. Common stock positions in Q2 2024 and 22 closed out, a net change of -4 holders.
- The largest Pactiv Evergreen Inc. Common stock buyer in Q2 2024 was T. Rowe Price Investment Management, an estimated $21.3M added.
- The largest Pactiv Evergreen Inc. Common stock seller in Q2 2024 was Morgan Stanley, an estimated $4.17M sold.
Based on aggregated 13F filings for Q2 2024.